Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma
Berdeja, Jesus G, Hart, Lowell L, Mace, Joseph R, Arrowsmith, Edward R, Essell, James H, Owera, Rami S, Hainsworth, John D, Flinn, Ian W
Published in Haematologica (Roma) (01.05.2015)
Published in Haematologica (Roma) (01.05.2015)
Get full text
Journal Article
Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study
Burris, Howard A, Flinn, Ian W, Patel, Manish R, Fenske, Timothy S, Deng, Changchun, Brander, Danielle M, Gutierrez, Martin, Essell, James H, Kuhn, John G, Miskin, Hari P, Sportelli, Peter, Weiss, Michael S, Vakkalanka, Swaroop, Savona, Michael R, O'Connor, Owen A
Published in The lancet oncology (01.04.2018)
Published in The lancet oncology (01.04.2018)
Get full text
Journal Article
A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy
Yalniz, Fevzi F., Berdeja, Jesus G., Maris, Michael B., Lyons, Roger M., Reeves, James A., Essell, James H., Patel, Prapti, Sekeres, Mikkael, Hughes, Amanda, Mappa, Silvia, Garcia‐Manero, Guillermo
Published in British journal of haematology (01.02.2020)
Published in British journal of haematology (01.02.2020)
Get full text
Journal Article
A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia
Donnellan, William, Berdeja, Jesus G., Shipley, Diana, Arrowsmith, Edward R., Wright, David, Lunin, Scott, Brown, Richard, Essell, James H., Flinn, Ian W.
Published in The oncologist (Dayton, Ohio) (01.10.2017)
Published in The oncologist (Dayton, Ohio) (01.10.2017)
Get full text
Journal Article
Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study
Rothenberg, Mace L., Liu, P.Y., Wilczynski, Sharon, Nahhas, William A., Winakur, Gaye L., Jiang, Caroline S., Moinpour, Carol M., Lyons, Ben, Weiss, Geoffrey R., Essell, James H., Smith, Harriet O., Markman, Maurie, Alberts, David S.
Published in Gynecologic oncology (01.12.2004)
Published in Gynecologic oncology (01.12.2004)
Get full text
Journal Article
A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory multiple myeloma (CAMMOUFLAGE trial)
Berdeja, Jesus G., Martin, Thomas G., Rossi, Adriana, Essell, James H., Siegel, David Samuel DiCapua, Mailankody, Sham, Saini, Neeraj, Holmes, Houston, Dhakal, Binod, Gasparetto, Cristina J., Parekh, Samir S., Portella, Socorro, Ledergor, Guy, Hammad, Ashley, Davi, Franco, Skoble, Justin, Garner, Elizabeth, Kanner, Steven Brian, Rizvi, Syed, Jagannath, Sundar
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Outreach: Preliminary safety and efficacy results from a phase 2 study of lisocabtagene maraleucel (liso-cel) in the nonuniversity setting
Godwin, John E., Mattar, Bassam Ibrahim, Maris, Michael B., Bachier, Carlos R., Stevens, Don A., Hoda, Daanish, Varela, Juan Carlos, Cherry, Mohamad, Fanning, Suzanne R., Essell, James H., Yimer, Habte Aragaw, Courtright, Jay G., Sharman, Jeff Porter, Trede, Nikolaus S., Youssef, Marina, Lymp, James, Shaughnessy, Paul
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease
Shaughnessy, Paul J., Bachier, Carlos, Grimley, Michael, Freytes, Cesar O., Callander, Natalie S., Essell, James H., Flomenberg, Neal, Selby, George, Lemaistre, C.F.
Published in Biology of blood and marrow transplantation (01.03.2005)
Published in Biology of blood and marrow transplantation (01.03.2005)
Get full text
Journal Article
The efficacy of duvelisib monotherapy following disease progression on ofatumumab monotherapy in patients with relapsed/refractory CLL or SLL in the DUO crossover extension study
Kuss, Bryone J., Davids, Matthew Steven, Hillmen, Peter, Essell, James H., Moreno, Carol, Lamanna, Nicole, Nagy, Zsolt, Tam, Constantine Si Lun, Stilgenbauer, Stephan, Jäger, Ulrich, Ghia, Paolo, Delgado, Julio, Le, Ngocdiep T., Jeglinski, Brenda, Montillo, Marco
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A phase I/II study of the combination of panobinostat (PAN) and carfilzomib (CFZ) in patients (pts) with relapsed or relapsed/refractory multiple myeloma (MM)
Berdeja, Jesus G., Gregory, Tara K., Matous, Jeffrey, Hart, Lowell L., Owera, Rami, Mace, Joseph Ronald, Essell, James H., Flinn, Ian, Faber, Edward Anthony
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A Phase I/II Study of the Combination of Panobinostat (PAN) and Carfilzomib (CFZ) in Patients (pts) with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Comparison of Two Expansion Cohorts
Berdeja, Jesus G., Gregory, Tara B., Faber, Edward A., Matous, Jeffrey V., Hart, Lowell L., Mace, Joseph R., Peyton, James D., Essell, James H., Arrowsmith, Edward R., Flinn, Ian W.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues
PELSTRING, R. J, ESSELL, J. H, KURTIN, P. J, COHEN, A. R, BANKS, P. M
Published in American journal of clinical pathology (01.12.1991)
Published in American journal of clinical pathology (01.12.1991)
Get full text
Journal Article
DYNAMO: A phase 2 trial of the PI3K-δ,γ inhibitor IPI-145 in patients with refractory indolent non-Hodgkin lymphoma
Wagner-Johnston, Nina, Strickland, Donald K, Wright, David Donald, Tetreault, Scott A., Lunin, Scott D., Essell, James H., Webb, Charles D., Langdon, Robert M., Farber, Charles M., Nimeh, Nadim F., Marris, Mike, Coleman, Teresa A., Kelly, Patrick Francis, Steelman, Lori, Dewar, Karen, Pimental, Patricia, Flinn, Ian
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
DUO: A phase 3 trial of the PI3K-δ,γ inhibitor IPI-145 versusofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma
Flinn, Ian, Jäger, Ulrich, Offner, Fritz, Cymbalista, Florence, Hallek, Michael, Caligaris-Cappio, Federico, Delgado, Julio, Hillmen, Peter, Davids, Matthew Steven, Wright, David Donald, Essell, James H., Baker, Bartrum W, Cosolo, Walter, Kelly, Patrick Francis, Harris, Patricia, Han, Lixin, Patterson, Fiona, Stilgenbauer, Stephan
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial
Essell, J H, Schroeder, M T, Harman, G S, Halvorson, R, Lew, V, Callander, N, Snyder, M, Lewis, S K, Allerton, J P, Thompson, J M
Published in Annals of internal medicine (15.06.1998)
Published in Annals of internal medicine (15.06.1998)
Get more information
Journal Article
KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) – Long-Term Follow-up of a Phase 2a Study (KD025-208)
Weisdorf, Daniel J., Jagasia, Madan, Salhotra, Amandeep, Bachier, Carlos R., Zoghi, Behyar, Lazaryan, Aleksandr, Essell, James H., Green, Laurie S., Schueller, Olivier, Yang, Zhongming, Eiznhamer, David A., Aggarwal, Sanjay K., Blazar, Bruce R., Lee, Stephanie
Published in Biology of blood and marrow transplantation (01.03.2020)
Published in Biology of blood and marrow transplantation (01.03.2020)
Get full text
Journal Article
KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics (PD) and Updated Results
Jagasia, Madan, Salhotra, Amandeep, Bachier, Carlos R., Essell, James H, Weisdorf, Daniel J., Lazaryan, Aleksandr, Zoghi, Behyar, Green, Laurie S, Schueller, Olivier, Zanin-Zhorov, Alexandra, Weiss, Jonathan M, Eiznhamer, David A, Aggarwal, Sanjay K, Blazar, Bruce R., Lee, Stephanie J.
Published in Biology of blood and marrow transplantation (01.03.2019)
Published in Biology of blood and marrow transplantation (01.03.2019)
Get full text
Journal Article
Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)
Lazaryan, Aleksandr, Lee, Stephanie J., Salhotra, Amandeep, Jagasia, Madan, Essell, James H., Zanin-Zhorov, Alexandra, Gillivray, Beth Mac, Schueller, Olivier, Eiznhamer, David A., Blazar, Bruce R., Ryan, John L.
Published in Biology of blood and marrow transplantation (01.03.2018)
Published in Biology of blood and marrow transplantation (01.03.2018)
Get full text
Journal Article
38 - Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)
Lazaryan, Aleksandr, Lee, Stephanie J., Salhotra, Amandeep, Jagasia, Madan, Essell, James H., Zanin-Zhorov, Alexandra, Gillivray, Beth Mac, Schueller, Olivier, Eiznhamer, David A., Blazar, Bruce R., Ryan, John L.
Published in Biology of blood and marrow transplantation (01.03.2018)
Published in Biology of blood and marrow transplantation (01.03.2018)
Get full text
Journal Article